World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
39955
World Ranking
16382
National Ranking
8242

David F. Ransohoff publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David F. Ransohoff sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 222 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David F. Ransohoff D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David F. Ransohoff sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David F. Ransohoff is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily focuses on Medicine, with a significant emphasis on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, and Epidemiology.

Their work targets several main topics, including:

  • Colorectal Cancer Screening and Detection
  • Genetic factors in colorectal cancer
  • Gastric Cancer Management and Outcomes
  • Colorectal Cancer Surgical Treatments
  • Healthcare cost, quality, practices
  • Health Systems, Economic Evaluations, Quality of Life
  • Ferroptosis and cancer prognosis

David F. Ransohoff has contributed to multiple research papers, some of which have been published in notable venues. Recent publications include:

  • Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy (2020), published in Cell
  • Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma (2020), published in Cell Reports
  • Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer (2020), published in UNC Libraries
  • An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles (2023), published in Gut
  • Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer (2025), published in Cell

Their frequent co-authors include Thomas F. Imperiale, Steven J. Skates, Christine D. Berg, Christopher R. Kinsinger, and Mehdi Mesri.

Ransohoff's publications appear predominantly in the following venues:

  • UNC Libraries
  • JNCI Journal of the National Cancer Institute
  • Annals of Internal Medicine
  • Cell
  • Gut

Best Publications

  • Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

    Karel G.M. Moons;Douglas G. Altman;Johannes B. Reitsma;John P.A. Ioannidis

  • Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications

    Robert H. Riddell;Harvey Goldman;David F. Ransohoff;Henry D. Appelman

  • Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests

    David F. Ransohoff;Alvan R. Feinstein

  • Multitarget Stool DNA Testing for Colorectal-Cancer Screening

    Thomas F. Imperiale;David F. Ransohoff;Steven H. Itzkowitz;Theodore R. Levin

  • Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.

    Thomas F. Imperiale;David R. Wagner;Ching Y. Lin;Gregory N. Larkin

  • Proteogenomic characterization of human colon and rectal cancer

    Bing Zhang;Jing Wang;Xiaojing Wang;Jing Zhu

  • Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.

    Thomas F. Imperiale;David F. Ransohoff;Steven H. Itzkowitz;Barry A. Turnbull

  • Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

    Terri A. Addona;Susan E. Abbatiello;Birgit Schilling;Steven J. Skates

  • Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

    Hui Zhang;Tao Liu;Zhen Zhang;Samuel H. Payne

  • Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

    Timothy Robert Church;Michael Wandell;Catherine Lofton-Day;Steven J Mongin

  • Rules of evidence for cancer molecular-marker discovery and validation

    David F Ransohoff;David F Ransohoff

  • Bias as a threat to the validity of cancer molecular-marker research

    David F. Ransohoff

  • Gastroesophageal reflux, Barrett esophagus, and esophageal cancer. Scientific review

    Nicholas Shaheen;David F. Ransohoff

  • Treatment adherence and risk of death after a myocardial infarction.

    R.I. Horwitz;C.M. Viscoli;R.M. Donaldson;C.J. Murray

  • Nonpolypoid neoplastic lesions of the colorectal mucosa.

    Shin ei Kudo;René Lambert;John I. Allen;Hiroaki Fujii

  • Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.

    Suhas Vasaikar;Chen Huang;Xiaojing Wang;Vladislav A. Petyuk

  • Addressing overdiagnosis and overtreatment in cancer: a prescription for change

    Laura J Esserman;Ian M Thompson;Brian Reid;Peter Nelson

  • European guidelines for quality assurance in colorectal cancer screening and diagnosis : Overview and introduction to the full Supplement publication.

    L. Von Karsa;J. Patnick;J. Patnick;N. Segnan;W. Atkin

  • Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics

    James E. Allison;Lori C. Sakoda;Theodore R. Levin;Jo P. Tucker

  • Are Physicians Doing Too Much Colonoscopy? A National Survey of Colorectal Surveillance after Polypectomy

    Pauline A. Mysliwiec;Martin L. Brown;Carrie N. Klabunde;David F. Ransohoff

Frequent Co-Authors

Steven A. Carr
Steven A. Carr Broad Institute
daniel c liebler
daniel c liebler Vanderbilt University
Amanda G. Paulovich
Amanda G. Paulovich Fred Hutchinson Cancer Research Center
David L. Tabb
David L. Tabb Stellenbosch University
Michael Pignone
Michael Pignone The University of Texas at Austin
John P. A. Ioannidis
John P. A. Ioannidis Stanford University
Richard D. Smith
Richard D. Smith Pacific Northwest National Laboratory
Christopher J. O'Donnell
Christopher J. O'Donnell Harvard Medical School
Michael Snyder
Michael Snyder Stanford University
Li Ding
Li Ding Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn’t always start or end with an MD. Many students consider diverse online programs to advance in healthcare, public health, or nursing roles. For those interested in healthcare administration, online mha programs cahme accredited offer flexible learning and leadership skills, making them ideal for professionals aspiring to managerial positions.

Nursing professionals can also benefit from online study. If you’re looking to earn a bachelor’s degree quickly, consider rn to bsn online no clinicals programs, which minimize required in-person training, helping experienced RNs upskill efficiently.

For advanced practice, doctoral options are expanding online. Students seeking a swift transition from MSN to DNP should review the fastest msn to dnp program, offering expedited pathways to top credentials. If flexibility and manageable coursework are priorities, some of the easiest online dnp programs allow working professionals to balance studies with career demands.

These growing online degree choices make healthcare careers and advancement more accessible for diverse student needs and schedules.

Best Scientists Citing David F. Ransohoff

Trending Scientists

Recently Published Articles